New technologies and potential cost savings related to morbidity and mortality reduction in Class III/IV heart failure patients in Canada

International Journal of Cardiology

Volumn 88, Issue 1, 2003, Pages 33-41

  Bentkover, Judith D ^a   Stewart, Edward J ^a   Ignaszewski, Andrew ^b   Lepage, Serge ^c   Liu, Peter ^d   Cooper, Jill ^a  

^a Innovative Health Solutions   (United States)

^b ST PAUL S HOSPITAL   (Canada)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^d TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Canada; Cardiac resynchronization therapy; Heart failure; Pharmacoeconomics

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAGNESIUM; POTASSIUM; SPIRONOLACTONE; WARFARIN;

ARTICLE; CANADA; CONTROLLED STUDY; COST CONTROL; DIAGNOSTIC TEST; EXERCISE TOLERANCE; HEALTH CARE COST; HEALTH ECONOMICS; HEART FAILURE; HOSPITALIZATION; HUMAN; LABORATORY TEST; MEDICAL CARE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL;

EID: 0037339744     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00378-9     Document Type: Article

References (30)

1. American Heart Association. Heart and stroke statistical update. Dallas, TX: American Heart Association, 2000, http://www.americanheart.org/statistics/ (accessed on October 24, 2001).
2. McAlister F.A., Teo K.K., Taher M., et al. Insights into the contemporary epidemiology and outpatient management of congestive heart failure. Am Heart J. 138:(1):1999;87-94.
3. Montague T., Barnes M., Taylor L., et al. Assessing appropriateness of treatment. A case study of transplantation in older patients with congestive heart failure. Can J Cardiol. 12:(1):1996;47-52.
4. Teo K.K., Ignaszewski A.P., Gutierrez R., et al. Contemporary medical management of left ventricular dysfunction and congestive heart failure. Can J Cardiol. 8:(6):1992;611-619.
5. Ackman M.L., Karim S.H., Mansell G., et al. Cause-specific non-cardiac mortality in patients with congestive heart failure: a contemporary Canadian audit. Can J Cardiol. 12:(9):1996;809-813.
6. Clinical advisor estimates, 2000.
7. Clinical Quality Improvement Network (CQIN) Investigators. Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure. Arch Intern Med 1996;156:1669-73.
8. Brophy J.M., DesLauriers G., Rouleau J.L. Long-term prognosis of patients presenting to the emergency room with decompensated congestive heart failure. Can J Cardiol. 10:(5):1994;537-543.
9. Tu J.V., Zhang H. Congestive heart failure outcomes in Ontario. Naylor D.C., Slaughter P.M. Cardiovascular health and services in Ontario: an ICES atlas report. 1999;111-122 Institute for Clinical Evaluative Sciences, Toronto.
10. Gillis A.M., Goldman B.S., Yee R., et al. Cardiac pacing in Canada in 1998: working towards optimal pacing therapy. Can J Cardiol. 14:(9):1998;1115-1120.
11. Goldman B.S., Nishimura S., Lau C. Survey of cardiac pacing in Canada. Can J Cardiol. 12:(6):1996;573-578.
12. Cardiovascular Drugs 24:08, Ontario drug benefit formulary/comparative drug index no. 36, Ministry of Health and Long-Term Care, Ontario, December 31, 1998.
13. Schedule of Benefit for Physician Service (Ontario Health Insurance Act), Consultation and Visit Fee, Ministry of Health and Long-Term Care, Ontario, July 1, 2000.
14. Schedule of Benefit for Physician Service (Ontario Health Insurance Act), Diagnostic and Therapeutic Procedure Fee Schedule, July 1, 2000.
15. McGregor M. Implantable ventricular assist devices: is it time to introduce them in Canada. Can J Cardiol. 16:(5):2000;629-640.
16. Heart Institute of Spokane, http://www.this.org/phade/phys_intro.html#cost, 1999 (accessed on June 10, 2000).
17. Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project, http://www.ahrq.gov/data/hcup, 1996 (accessed on June 10, 2000).
18. Cline C.M.J., Israelsson B.Y.A., Willenheimer R.B., et al. Cost effective management programme for heart failure reduces hospitalization. Heart. 80:1998;442-446.
19. Lasater M. The effect of a nurse-managed CHF clinic on patient readmission and length of stay. Home Healthcare Nurse. 14:1996;351-356.
20. Van Meter C.H., Ordoyne S.K.H., Kateiva J.E. Ventricular assist device programs: design and function. Ann Thorac Surg. 68:1999;643-645.
21. O'Connell J.B. The economic burden of heart failure. Clin Cardiol. 23:(Suppl III):2000;6-10.
22. Reiss S.E., Holubkov R., Edmundowicz D., et al. Treatment of patients admitted to hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes. J Am Coll Cardiol. 30:1997;733-738.
23. Mussivand T., Paganini E.P., Oz M.C., et al. Cost effectiveness of artificial organ therapy. ASAIO. 44:(4):1998;253-258.
24. Paul S.D., Kuntz K.M., Eagle K.A., et al. Cost and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure. Arch Intern Med. 154:1994;1143-1149.
25. Ansari M.N., Tutar A., Teerlink J.R., et al. ACE inhibitor and beta-blocker use in CHF outpatients: are we translating clinical trials into practice? Circulation. 100:(18):1999;I-538.
26. Auerbach A.D., Hamel M.B., Davis R.B., et al. Resource use and survival of patients hospitalized with congestive heart failure: differences in care by specialty of the attending physician. Ann Intern Med. 132:(3):2000;191-200.
27. Boyko W.L., Glick H.A., Schulman K.A. ACE inhibitors in the management of congestive heart failure: comparative economic data. Am Heart J. 137:(5):1999;S115-S119.
28. Paul S.D., Kuntz K.M., Eagle K.A., et al. Cost and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure. Arch Intern Med. 154:1994;1143-1149.
29. Peters R.W., Gold M.R. Pacing for patients with congestive heart failure and dilated cardiomyopathy. Cardiac Pacing. 18:(1):2000;55-66.
30. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 341:(10):1999;709-717.